These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27237021)

  • 1. Factors affecting hospital costs in lung cancer patients in the United Kingdom.
    Kennedy MP; Hall PS; Callister ME
    Lung Cancer; 2016 Jul; 97():8-14. PubMed ID: 27237021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary-care costs associated with lung cancer diagnosed at emergency hospitalisation in the United Kingdom.
    Kennedy MPT; Hall PS; Callister MEJ
    Thorax; 2017 Oct; 72(10):950-952. PubMed ID: 28137919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and costs of treating lung cancer patients in a university hospital.
    Dedes KJ; Szucs TD; Bodis S; Joerger M; Lowy A; Russi EW; Steinert HC; Weder W; Stahel RA
    Pharmacoeconomics; 2004; 22(7):435-44. PubMed ID: 15137882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of care associated with non-small-cell lung cancer in a commercially insured cohort.
    Hillner BE; McDonald MK; Desch CE; Smith TJ; Penberthy LT; Maddox P; Retchin SM
    J Clin Oncol; 1998 Apr; 16(4):1420-4. PubMed ID: 9552046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization Costs After Surgery in High-Risk Patients With Early Stage Lung Cancer.
    Sancheti MS; Chihara RK; Perez SD; Khullar OV; Fernandez FG; Pickens A; Force SD
    Ann Thorac Surg; 2018 Jan; 105(1):263-270. PubMed ID: 29174780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual cost of managing bipolar disorder to the UK healthcare system.
    Young AH; Rigney U; Shaw S; Emmas C; Thompson JM
    J Affect Disord; 2011 Oct; 133(3):450-6. PubMed ID: 21737141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Economic Impact of Clinical Research in an Italian Public Hospital: The Malignant Pleural Mesothelioma Case Study.
    Ippoliti R; Falavigna G; Grosso F; Maconi A; Randi L; Numico G
    Int J Health Policy Manag; 2018 Aug; 7(8):728-737. PubMed ID: 30078293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
    Kwan SW; Mortell KE; Hippe DS; Brunner MC
    J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Video-assisted thoracic surgery lobectomy cost variability: implications for a bundled payment era.
    Medbery RL; Perez SD; Force SD; Gillespie TW; Pickens A; Miller DL; Fernandez FG
    Ann Thorac Surg; 2014 May; 97(5):1686-92; discussion 1692-3. PubMed ID: 24792254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment pathways, resource use and costs in the management of small cell lung cancer.
    Oliver E; Killen J; Kiebert G; Hutton J; Hall R; Higgins B; Bourke S; Paschen B
    Thorax; 2001 Oct; 56(10):785-90. PubMed ID: 11562518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
    Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
    J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A UK retrospective observational study of clinical outcomes and healthcare resource utilisation of infliximab treatment in Crohn's disease.
    Lindsay JO; Chipperfield R; Giles A; Wheeler C; Orchard T;
    Aliment Pharmacol Ther; 2013 Jul; 38(1):52-61. PubMed ID: 23701393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.
    Yap KK; Yap KS; Byrne AJ; Berlangieri SU; Poon A; Mitchell P; Knight SR; Clarke PC; Harris A; Tauro A; Rowe CC; Scott AM
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1033-40. PubMed ID: 15875178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic implications of multiple births: inpatient hospital costs in the first 5 years of life.
    Henderson J; Hockley C; Petrou S; Goldacre M; Davidson L
    Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F542-5. PubMed ID: 15499151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Pennington M; Gentry-Maharaj A; Karpinskyj C; Miners A; Taylor J; Manchanda R; Iyer R; Griffin M; Ryan A; Jacobs I; Menon U; Legood R
    PLoS One; 2016; 11(11):e0165539. PubMed ID: 27829038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan.
    Chiang JK; Kao YH; Lai NS
    PLoS One; 2015; 10(9):e0138773. PubMed ID: 26406871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
    Stewart S; McMurray JJ; Hebborn A; Coats AJ; Packer M;
    Int J Cardiol; 2005 Apr; 100(1):143-9. PubMed ID: 15820297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
    Verboom P; van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; van Mourik JC; Postmus PE; Boers M; Grijseels EW; Teule GJ; Uyl-de Groot CA;
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1444-9. PubMed ID: 14579081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.